Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222
- PMID: 159309
- PMCID: PMC12253729
- DOI: 10.1007/BF00411108
Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222
Abstract
The newly synthesized nitrosoureas 1-(2-chloroethyl)-1-nitroso-3-(methylenecarboxamido)-urea (Acetamido-CNU), 1-(2-chloroethyl)-1-nitroso-3-(4-morpholino)-urea (Morpholino-CNU), 1-(2-chloroethyl)-1-nitroso-3-(1-piperidino)-urea (Piperidino-CNU), and 2-[3-(2-chloroethyl)-3-nitrosoureido]-ethylmethanesulfonate (Ethylmethanesulfonato-CNU) were compared in their chemotherapeutic activity against preterminal rat leukemia L 5222 with BCNU, CCNU, MeCCNU, Chlorozotocin, and Hydroxyethyl-CNU. With respect to the dose range effecting a median survival time of more than 90 days, MeCCNU was superior to the other substances. Chlorozotocin, on the other hand, was the only substance which achieved no cures in this experimental arrangement. From the four newly introduced substances the water-soluble substances Acetamido-CNU and Morpholino-CNU were approximately comparable to CCNU with regard to the dose range effecting a median survival time of greater than 90 days. Piperidino-CNU and Ethylmethanesulfonato-CNU also effected cures; however, only Piperidino-CNU in one dosage effected a median survival time of greater than 90 days.
Die therapeutische Aktivität der vier neusynthetisierten Nitrosoharnstoffe 1-(2-Chlorethyl)-1-nitroso(3-methylencarboxamido)-harnstoff (Acetamido-CNU), 1-(2-Chlorethyl)-1-nitroso-3-(4-morpholino)-harnstoff (Morpholino-CNU), 1-(2-Chlorethyl)-1-nitroso-3-(1-piperidino)-harnstoff (Piperidino-CNU) und 2-[3-(2-Chlorethyl)-3-nitrosoureido]-ethylmethansulfonat (Ethylmethansulfonato-CNU) wurde an der präterminalen Rattenleukämie L 5222 mit der Wirkung von BCNU, CCNU, MeCCNU, Chlorozotocin und Hydroxyethyl-CNU verglichen.
MeCCNU war den anderen Substanzen im Hinblick auf den breiten Dosisbereich, in dem eine mediane Überlebenszeit von >90 Tagen bewirkt wurde, überlegen. Chlorozotocin dagegen bewirkte als einzige Substanz in dieser Versuchsanordnung keine Heilungen. Von den neu vorgestellten Substanzen waren die wasserlöslichen Verbindungen Acetamido-CNU und Morpholino-CNU im Hinblick auf die Breite des Dosisbereiches, in dem eine mediane Überlebenszeit von >90 Tagen erzielt wurde, annähernd dem CCNU vergleichbar. Piperidino-CNU und Ethylmethansulfonato-CNU bewirkten auch Heilungen; jedoch wurde nur mit einer Dosierung von Piperidino-CNU eine mediane Überlebenszeit von >90 Tagen erreicht.
Similar articles
-
Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.J Cancer Res Clin Oncol. 1981;101(3):285-302. doi: 10.1007/BF00410114. J Cancer Res Clin Oncol. 1981. PMID: 7309781 Free PMC article.
-
Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222.Oncology. 1981;38(1):39-42. doi: 10.1159/000225519. Oncology. 1981. PMID: 7443175
-
Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.Arzneimittelforschung. 1982;32(5):481-4. Arzneimittelforschung. 1982. PMID: 6285938
-
What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.J Neurooncol. 2009 Jan;91(2):117-25. doi: 10.1007/s11060-008-9697-z. Epub 2008 Sep 24. J Neurooncol. 2009. PMID: 18813876
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
Cited by
-
Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.J Cancer Res Clin Oncol. 1981;101(3):285-302. doi: 10.1007/BF00410114. J Cancer Res Clin Oncol. 1981. PMID: 7309781 Free PMC article.
-
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).J Cancer Res Clin Oncol. 1986;112(1):47-9. doi: 10.1007/BF00394938. J Cancer Res Clin Oncol. 1986. PMID: 3733867 Free PMC article.
-
Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids.J Cancer Res Clin Oncol. 1984;108(2):249-51. doi: 10.1007/BF00402478. J Cancer Res Clin Oncol. 1984. PMID: 6470033 Free PMC article.
-
Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.Cancer Chemother Pharmacol. 1983;11(3):147-52. doi: 10.1007/BF00254194. Cancer Chemother Pharmacol. 1983. PMID: 6227420
-
New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.J Cancer Res Clin Oncol. 1986;111(2):154-6. doi: 10.1007/BF00400755. J Cancer Res Clin Oncol. 1986. PMID: 3700459 Free PMC article.
References
-
- Carter, S.K. (ed).: Proceedings of the seventh new drug seminar on the nitrosoureas (Washington, DC, Dec. 15–16, 1975). Cancer Treat. Rep. 60, 645–811 (1976)
-
- Carter, S.K., Wassermann, T.H.: The nitrosoureas-thoughts for the future. Cancer Treat. Rep. 60, 807–811 (1976) - PubMed
-
- Eisenbrand, G., Fiebig, H.H., Zeller, W.J.: Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential. Z. Krebsforsch. 86, 279–286 (1976) - PubMed
-
- Ivankovic, S., Zeller, W.J.: Leukämie L 5222 des Rattenstammes BD IX. Eine durch Äthylnitrosoharnstoff induzierte monozytär-myeloische, transplantierbare Form für zytochemische und chemotherapeutische Studien. Blut 28, 288–292 (1974) - PubMed
-
- Johnston, T.P., McCaleb, G.S., Montgomery, J.A.: Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. J. Med. Chem. 18, 104–106 (1975) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources